A phase 2, two-stage study of avelumab and axitinib in patients with mismatch repair-proficient (MMR-P) recurrent or persistent endometrial cancer (EC).
Avelumab;Axitinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A phase 2, two-stage study of avelumab and axitinib in patients with mismatch repair-proficient (MMR-P) recurrent or persistent endometrial cancer (EC). ### Output: Avelumab;Axitinib